Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register.
about
Postpartum women's use of medicines and breastfeeding practices: a systematic reviewUse of inhaled and oral corticosteroids in pregnancy and the risk of malformations or miscarriageTrends and Determinants of Prescription Drug Use during Pregnancy and Postpartum in British Columbia, 2002-2011: A Population-Based Cohort StudyDoes Use of Low-Molecular-Weight Heparin during Pregnancy Influence the Risk of Prolonged Labor: A Population-Based Cohort StudyMethodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy.Antibiotic exposure in pregnancy and risk of coeliac disease in offspring: a cohort study.Antidepressant use during pregnancy: comparison of data obtained from a prescription register and from antenatal care records.Asthma during pregnancy in a population-based study--pregnancy complications and adverse perinatal outcomes.Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.Antidepressant use and risk for preeclampsia.Drug use during early pregnancy: cross-sectional analysis from the Childbirth and Health Study in Primary Care in Iceland.Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score.Use of palivizumab is underestimated in the Swedish Prescribed Drug Register - implications for register-based drug studies.Use of prescribed drugs among primiparous women: an 11-year population-based study in DenmarkSelective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohortPrevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006.A review of antihistamines used during pregnancyRisks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study.Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study.Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United StatesUse of proton pump inhibitors and subsequent risk of celiac diseasePsychotropic Medication and Substance Use during Pregnancy by Women with Severe Mental Illness.Ibuprofen results in alterations of human fetal testis development.Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.Analgesic use - prevalence, biomonitoring and endocrine and reproductive effects.The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis.Long-term Use of Z-Hypnotics and Co-medication with Benzodiazepines and Opioids.Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.Antidepressants during pregnancy and autism in offspring: population based cohort study.Medication use among pregnant women with systemic lupus erythematosus and general population comparators.Exposure to systemic antibacterial medications during pregnancy and risk of childhood cancer.Use of macrolides during pregnancy and the risk of birth defects: a population-based study.Hypnotics use in children 0-18 months: moderate agreement between mother-reported survey data and prescription registry data.Pregnant women's view on the Swedish internet resource Drugs and Birth Defects intended for health care professionals.Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases.Agreement Between Maternal Report and Medical Records During Pregnancy: Medications for Rheumatoid Arthritis and Asthma.Drugs and Birth Defects: a knowledge database providing risk assessments based on national health registers.
P2860
Q26777902-1C1C1ABC-ED88-4282-84D7-6C46EE7A1EDDQ26825323-5C6E2119-9026-4AB3-A1F2-95491C7269BBQ28547467-8F5911EF-C042-4C51-8DCA-2EFC77ABB2DDQ28550259-5493C537-0256-475F-BA14-20B97B72040BQ30840124-3FB818AB-165B-4FA5-AB36-B93BFEAEB4B1Q33611585-4DB749C2-31B4-423D-9C6B-9C13F2DBCE5AQ33841097-B6A272CC-EA32-4AC5-A36D-21F39BB10EEBQ34070735-65791A9F-F69F-4D29-B2CA-0A0BCED13934Q34073546-C5CB2E7E-5784-44CB-A024-A3A756A640C2Q34158083-CE2921F6-4F4C-40AC-93F2-A81A01B0D32EQ34388914-2E004263-A7EE-49E8-A748-068AD1C24FC9Q34445231-9B3BC430-C753-4CF9-A120-D2198A2186ADQ34823724-AAE7577F-C457-4237-B01E-DEF0D4E58C53Q34987204-44A5C880-A526-44AA-9264-B3FD5CE3C693Q35541040-1FABBFCF-A4B6-470B-82FB-82F73327D255Q35853142-5D263C4D-6E0D-4B7A-80D7-E8BEEB441C00Q35891733-CF05B3C8-1252-4F03-96C7-B1C7C2A24CD5Q35975200-A63C6FEB-C46C-43AC-B4CF-05D44576CB33Q36386092-CE11A4FE-16F5-4FBD-BD1C-538BB00CFDF3Q36779955-638A26C1-652D-4AD9-B8BD-40CD9E1DA575Q36853542-F407FECF-D870-4551-934E-5490D9511689Q37109230-5CB4E8B9-F041-4601-B35A-1C9743684E6CQ37625863-34E5753C-83C5-4632-B295-8BB0E86B483AQ37647623-8D712A4A-4975-40F5-B6DB-A39A524DDA33Q37692388-1731FD9C-05F3-4757-BD79-6C2223F917ACQ37943435-9271BEA0-55DB-4620-B541-6FD358827BD8Q38109104-2D176984-56A5-4299-9F9C-FFBD9D80F5BEQ38826794-93CDBC68-FF1B-4510-B421-195522297290Q39017678-3A59FC98-5ED8-448B-B086-A3FAE2E9B8F0Q39311482-9BA77A30-D55B-4BE6-B46A-BE72045A1312Q40113622-71D40B82-CC68-4E3D-9DC0-04C00F74D076Q40116223-A4A80675-CDDF-4CBC-B071-B37DB6ABE91AQ40408617-10685A6F-1E86-4D42-B673-5678428025E2Q40880236-21E3B762-8A86-4F86-B77E-A865FF3991C9Q41172176-58435375-C3B8-4BE4-B93B-8C3567B312C6Q41467952-4D188280-1B4E-4A12-9BD8-2F804BB8F69BQ41638971-F1A8873B-5E9A-4DCD-B3B8-05E87B76E8B4Q43561035-654D3255-E8F1-41AB-BF0B-3C5E96B0899FQ43576495-CD555F3A-70B4-4F48-99B7-1DDCA38EDD7EQ43675521-771E1D11-6E82-4C61-B9C8-24BA86C33377
P2860
Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Drug use during pregnancy in S ...... nd the Medical Birth Register.
@ast
Drug use during pregnancy in S ...... nd the Medical Birth Register.
@en
Drug use during pregnancy in S ...... nd the Medical Birth Register.
@nl
type
label
Drug use during pregnancy in S ...... nd the Medical Birth Register.
@ast
Drug use during pregnancy in S ...... nd the Medical Birth Register.
@en
Drug use during pregnancy in S ...... nd the Medical Birth Register.
@nl
prefLabel
Drug use during pregnancy in S ...... nd the Medical Birth Register.
@ast
Drug use during pregnancy in S ...... nd the Medical Birth Register.
@en
Drug use during pregnancy in S ...... nd the Medical Birth Register.
@nl
P2093
P2860
P356
P1476
Drug use during pregnancy in S ...... nd the Medical Birth Register.
@en
P2093
Bengt Haglund
Fredrik Granath
Helle Kieler
Tobias Svensson
P2860
P356
10.2147/CLEP.S16305
P407
P577
2011-02-01T00:00:00Z